OCEA: Ocean Biomedical Inc Kompaniya qiymatining sof foydaga nisbati
Ocean Biomedical, Inc. universitetlar bilan ilmiy ittifoqlar orqali immunologiya va onkologiya sohalarida innovatsiyalarni joriy etmoqda hamda dori vositalarini bozorga chiqarish uchun sinergiya yaratmoqda. Quyida keltirilgan kotirovkalar, bunda P/E koeffitsiyenti -0.10 ga teng, ushbu ishlanmalarni tayyor texnologiyalarning tezlashtirilgan litsenziyalash bo'yicha rahbariyat strategiyasi bilan bog'laydi. Kompaniyaning faoliyati FDA standartlari bilan qat'iy tartibga solinadi, bu esa uning eko-strategiyasini faqat biomateriallarning tegishli ravishda utilizatsiya qilinishi bilan cheklaydi.
%20P%2FE%20multiplikatori&width=1200&height=400&colorIndex=0&v=mwczyyub.rjb-7czcsu8&start=20220704&end=20261112&filename=GURU_Markets_-_OCEA_-_Ocean-Biomedical-Inc._-_PE-Multiple "OCEA: Ocean Biomedical, Inc. Biznesning o‘zini qoplash muddati 28.04.2023 - 26.04.2025 | 👁️GURU.Markets👁️")
Ocean Bio (OCEA) kompaniyasining tahliliy kesimlari
- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi haqida ma'lumot:
- buxgalteriya balansi bo'yicha sof aktivlar qiymati ko'rsatkichlari:
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning xususiy kapitalga nisbati Ocean Biomedical, Inc.|OCEA - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati Ocean Biomedical Corp|OCEA - Kompaniya qarzlari|Qarzning balans qiymatiga nisbati Ocean Biomedical, Inc.|OCEA - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarz Ocean Biomedical|Shoshilinch likvidlik oceanbiomedical.com
- foyda va bozor multiplikatorlari tafsilotlari:
OCEA - Sof foyda|Kelajakdagi foyda Ocean Biomedical, Inc.|OCEA - P/E multiplikatori|Prognoz qilingan narx-foyda nisbati Ocean Biomedical Inc|OCEA - PEG multiplikatori|EV/EBITDA multiplikatori Ocean Biomedical, Inc.|OCEA - Foizlar, soliqlar va eskirish to'lanishidan oldingi foyda|So'nggi 12 oy davomida bir aksiya uchun foyda Ocean Biomedical|OCEA - So'nggi 12 oy davomida bir aksiya uchun sof foyda|So'nggi 12 oy davomida bitta aksiya uchun foydaning yillik o'sishi oceanbiomedical.com|OCEA - Joriy yilda foyda o'sishi|Keyingi yil uchun bir aksiya uchun sof foyda o'sishi prognozi Ocean Biomedical, Inc.
Kompaniyaning har tomonlama tahlili:oceanbiomedical.com OCEA
Portfel menejerlari Ocean Biomedical, Inc. (OCEA) ilmiy ishlanmalarining tijorchashtirish samaradorligini yakindan kuzatmoqdalar. P/E koeffitsiyenti sof foydaning bir birligining bozor qiymatini aks ettirib, investorlarning kelajakdagi o'sish uchun qanchalik ortiqcha to'lov qilayotganini o'lchaydi. Biznesning joriy P/E koeffitsiyentini tahlil qilish akademik R&D modelidagi baholashning haddan tashqari oshganini aniqlash imkonini beradi. Ushbu koeffitsiyentning tendentsiyasi, agar marjalar pasaysa, korreksiya xavfi borligidan signal beradi. Bu biotexnologiya kompaniyasining kapitalizatsiyasi barqarorligini tasdiqlaydi.
Muhim raqobatchilar
P/E multiplikatori argenx.com|Narx-foyda koeffitsiyenti BNTX (BioNTech)|ABVX (ABIVAX) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori ADMA (ADMA Bio)|Biznesning o‘zini qoplash muddati Protagonist Corp (PTGX)|IMVT - Narxning foydaga nisbati|kiniksa.com (KNSA) - Narx-foyda koeffitsiyenti|Grifols (GRFS) - Narxning foydaga nisbati|Narx-foyda koeffitsiyenti Adaptive Biotech|Narx-foyda koeffitsiyenti CLDX|P/E multiplikatori Aurinia Corp|Narxning foydaga nisbati BioCryst (BCRX)|veratx.com - Narx-foyda multiplikatori|P/E multiplikatori DNTH (Dianthus Therapeutics, Inc.)|Pharvaris NV (PHVS) - Kapitalizatsiyaning foydaga nisbati|ABCL - Narxning foydaga nisbati|Kapitalizatsiyaning foydaga nisbati Tourmaline|PGEN: P/E multiplikatori|Narx-foyda koeffitsiyenti pharming.com|NKTR (Nektar Therapeutics Inc.) - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Upstream Bio, Inc. UPB|P/E multiplikatori ZBIO|P/E multiplikatori Immunome Bio (IMNM)|Narxning foydaga nisbati Gossamer Bio, Inc. GOSS|KALV: Narx-foyda multiplikatori|SEPN: Narx-foyda koeffitsiyenti|Kompaniya qiymatining sof foydaga nisbati PVLA (Pieris Pharma)|SVRA: P/E multiplikatori|RIGL (Rigel Corp) - Narxning foydaga nisbati|ANAB (AnaptysBio, Inc.) - P/E multiplikatori|astriatx.com (ATXS) - Biznesning o‘zini qoplash muddati|Narxning foydaga nisbati enGene (ENGN)|RAPT - Kapitalizatsiyaning foydaga nisbati|Narxning foydaga nisbati Aerovate Therapeutics JBIO|ACRS - Narx-foyda koeffitsiyenti|Kyverna Therapeutics - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati tizianalifesciences.com|CABA: P/E multiplikatori|Narx-foyda multiplikatori VTYX|THTX (Theratechnologies Inc) - P/E multiplikatori|Avalo Therapeutics Inc (AVTX) - Biznesning o‘zini qoplash muddati|P/E multiplikatori ELDN|Narx-foyda koeffitsiyenti agenusbio.com AGEN|P/E multiplikatori CLYM (Climb Bio)|P/E multiplikatori Zura Bio Ltd ZURA|ATYR - Narxning foydaga nisbati|ADAG: Narxning foydaga nisbati|IMA (ikenaoncology.com) - Narx-foyda koeffitsiyenti|Shattuck Labs - Kompaniya qiymatining sof foydaga nisbati|EQ (Equillium Inc) - P/E multiplikatori|Connect Pharma (CNTB) - Biznesning o‘zini qoplash muddati|Narxning foydaga nisbati Immunic, Inc. (IMUX)|atarabio.com - Narx-foyda multiplikatori|P/E multiplikatori IFRX (InflaRx)|XFOR - Narx-foyda koeffitsiyenti|ACET: Narx-foyda koeffitsiyenti|Biznesning o‘zini qoplash muddati Celularity Inc. CELU|INmune Bio Corp (INMB) - Narxning foydaga nisbati|Kapitalizatsiyaning foydaga nisbati Barinthus Biotherapeutics Corp (BRNS)|KZR (Kezar Life Sciences) - P/E multiplikatori|Narx-foyda koeffitsiyenti sabbiotherapeutics.com (SABS)|P/E multiplikatori AKTX|ENLV - Kapitalizatsiyaning foydaga nisbati|P/E multiplikatori QTTB (Q32 Bio)|P/E multiplikatori GeoVax Corp GOVX|EDSA - Narxning foydaga nisbati|Kapitalizatsiyaning sof foydaga nisbati IBIO|CARM: P/E multiplikatori|XTL Biopharmaceuticals Ltd - Kompaniya qiymatining sof foydaga nisbati|BOLT (Bolt Biotherapeutics Inc.) - P/E multiplikatori|P/E multiplikatori HCW Biologics Inc|Narxning foydaga nisbati Aptevo Therapeutics (APVO)|AIM (AIM ImmunoTech, Inc.) - Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati Aditxt, Inc. ADTX|GRI - Narx-foyda koeffitsiyenti|XORTX - P/E multiplikatori|HIND - P/E multiplikatori|REVB (Revelation Biosciences) - Narx-foyda koeffitsiyenti|indaptusrx.com - Kompaniya qiymatining sof foydaga nisbati|SCNI (Scinai Immunotherapeutics Ltd.) - P/E multiplikatori|CalciMedica Corp (CALI) - Biznesning o‘zini qoplash muddati|Narxning foydaga nisbati Affimed (AFMD)|Narx-foyda koeffitsiyenti allakos.com ALLK|Narxning foydaga nisbati HOOKIPA Pharma HOOK|IGMS - Narx-foyda koeffitsiyenti|ITOS: Narx-foyda koeffitsiyenti|TCBP - P/E multiplikatori|Third Harmonic Bio, Inc (THRD) - Narxning foydaga nisbati
